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Abstract
Rhemannie Radix Preparata (RRP) has been previously employed in traditional oriental medicine as a treatment for diabetic thirst and improving
blood flow. The aim of this study was to evaluate its hypoglycemic control by assaying the activities of key enzymes of carbohydrate metabolism
in streptozotocin-(STZ)-induced diabetic rats. Further, RRP extracts were prepared in water (RRPW), in 50% ethanol (RRP50), and in 100% ethanol
(RRP100), respectively, and compared for their actions in diabetic rats. The oral treatment of RRP (5 mg/kg b.w./d) to diabetic rats for 21 days
resulted in a significant decline in blood glucose by 67% compared to diabetic control rats (P < 0.05). The altered activities of glucokinase, glucose-6-phosphate
dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (6PGD), and acetyl CoA carboxylase (ACC) in the livers of diabetic rats were reversed 
significantly to near-normal levels by the administration of RRP (P < 0.05). Among the three RRP extracts, RRP100 was the most effective in terms
of hypoglycemic action. However, the administration of RRP to diabetic rats did not improve insulin production. The modulatory effects of RRP100
on the attenuation of carbohydrate enzyme activities appear to hold promise for widespread use for the treatment of diabetes in the future.
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Introduction14)
Rhemannie Radix (RR) has been employed in traditional Asian 
medicine since approximately 200 B.C. It was classified as 
high-grade (very safe) medicine [1]. RR exists in three different 
types; unprocessed, dried, and processed RR. Dried-RR was 
prepared by peeling and drying of raw RR. The RR preparata 
(RRP) was prepared via the extraction of raw RR in Korea rice 
wine, Makgeolli, and nine repetitions of a steaming and drying 
procedure [2]. Compositional analysis of RRP showed that starch 
was degraded and total sugar was reduced, but the major marker 
constituent of RRP, 5-hydroxymethyl-2-furaldehyde (5-HMF) 
was gradually increased along with repeated processing, as 
compared with RR [3]. 
In particular, RRP differs significantly from raw RR in its 
usage in oriental medicine: Raw RR can reduce heat in the blood 
and promote the production of body fluid [1], whereas RRP can 
nourish ‘yin’, modulate diabetic thirst, and promote blood flow 
[4]. Based on the empirical clinical findings, a herbal formula 
containing RR evidenced anti-diabetic effects in neonatal 
streptozotocin (STZ)-induced rats [5]. Three radix extracts, 
including Rhemannia, Panax Ginseng, and Scutellariae improved 
insulin secretion and beta-cell proliferation via the induction of 
insulin receptor substrate 2 (IRS2) protein [6]. However, these 
anti-diabetic effects of RRP have been examined as a complex 
form rather than a single treatment. Moreover, the roles of RRP 
in glucose metabolism have not been particularly well 
established. 
Therefore, the principal objective of this study was to 
determine whether RRP extract exerts hypoglycemic activity in 
STZ-induced diabetic rats by modulating glucose metabolic 
enzymes. Moreover, we compared the activity of RRP using 
different extraction solutions including water, 50% ethanol and 
100% ethanol.
Materials and Methods
Preparation of RRP extract 
The RR preparata (RRP) was obtained from a commercial 
market (Keumsan, Korea), and prepared via the traditional 
production method (Fig. 1). The RRP was extracted with three 
kinds of solutions, or water, 50% ethanol and 100% ethanol, 
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Fig. 1. Rehmannie Radix Preparata (Sookjihwang)
which could show differen sugar or lipid extraction. The extraction 
processes were repeated 3 times at 100℃ for 5h with water, 
and at 25℃ for 24 h with 50% ethanol and 100% ethanol. The 
extracts were filtered and concentrated via vacuum evaporation 
and lyophilization (Savant SC 100A, Holbrook, NY, USA). 
Induction of experimental diabetes
Male Sprague-Dawley (4 week old, n = 20) rats were obtained 
from Orient Bio (Seongnam, Korea). Animals were maintained 
under environmentally-controlled conditions with a 12 h 
light/dark cycle at 22 ± 2℃ and a relative humidity of 50 ± 5%. 
They were acclimatized to the laboratory for 7 d before the 
experiments, and provided with free access to standard pellet 
chow diets (Purina Korea Inc., Korea) and water.
Experimental diabetes was induced in rats that had fasted for 
12 h via intraperitoneal injections of streptozotocin (STZ, 50 
mg/kg) dissolved in 0.1 M of cold citrate buffer (5 mM, pH 
4.5). Because STZ is capable of inducing fatal hypoglycemia 
as a consequence of massive pancreatic insulin release, the rats 
were provided with 10% glucose solution after 6h of STZ 
administration for the next 24h to prevent hypoglycemia. After 
a week to allow for the development and aggravation of diabetes, 
rats with moderate diabetes (i.e. blood glucose concentration, >
250 mg/dL) that evidenced glycosuria and hypoglycemia were 
selected for the experiments. Control littermates received only 
an injection of citrate buffer. All procedures involving animals 
were approved by the Experimental Animal Care Committee of 
Joongbu University, Choongnam, Korea. 
Experimental design 
After the successful induction of experimental diabetes, the rats 
were randomly divided into four groups, each comprising a 
minimum of five rats: Group 1: normal control (NC), Group 2: 
STZ-induced diabetic control (DC), Group 3: diabetic rats 
administered with RRP extract in 50% ethanol , Group 4: diabetic 
rats administered with RRP extract in 100% ethanol. Group 5: 
diabetic rats administered with RRP extract. After each RRP was 
diluted with water in ratio of 1 g/L, the amount of 5 mg/kg 
BW/d was fed through the mouth of rats by catheter for 21 days. 
The dosage of RRP in this study was adopted from traditional 
oriental medical prescriptions. Two control groups--a normal 
control (NC) and a diabetic control (DC)--received equal volumes 
of distilled water. At the end of the treatment period, the rats 
were fasted overnight, anaesthetized, and sacrificed via cervical 
decapitation. The blood and liver tissues were collected.
Biochemical estimations 
Blood glucose was estimated via the methods described by 
Sasaki et al. [7]. Insulin levels were measured in plasma using 
the sensitive rat insulin radioimmunoassay kit (Shibayagi, 
Shibukawa, Japan). A portion of the liver tissue was dissected 
out and immediately washed in ice-cold saline, and then 
homogenized in 0.1 M Tris-HCl buffer (pH 7.4) to identify the 
key enzymes of carbohydrate metabolism. The homogenates were 
centrifuged at 10,000 rpm to remove the debris and the supernatants 
were employed as an enzyme source for the assays of glucokinase, 
glucose-6-phosphate dehydrogenase (G6PD), 6-phosphogluconate- 
dehydrogenase (6PGD) and acetyl-CoA carboxylase (ACC), 
according to the methods described by Joo et al. [8].
Statistical analysis 
Results were expressed as means ± SD of five rats per group 
and statistical significance was assessed via one-way analysis of 
variance (ANOVA) and Duncan's multiple range test using SAS 
software. Values were considered statistically significant at P < 
0.05. 
Results 
The effects of RRP administration on fasting blood glucose 
and insulin levels in the streptozotocin (STZ)-injected rats are 
shown in Table 1. The diabetic animals evidenced statistically 
significant increases in fasting blood glucose as compared to the 
normoglycemic animals (P < 0.05). The treatment of STZ- 
induced diabetic animals with RRP for 21 days resulted in 
significant reductions in blood glucose levels compared to those 
measured in the diabetic control animals (P < 0.05). The 
hypoglycemic effect of RRP was altered slightly according to 
the extraction solutions, which was higher in the following order: 
RRP100 (67% of diabetic control), RRP50 (58% of diabetic 
control) and RRPW (49% of diabetic control). 
STZ also induced an apparent decline in insulin levels as shown 
in Table 1 (P < 0.05). The oral administration of RRP ethanol 
extract maintained the plasma insulin at the level observed for 
the diabetic control animals. Plasma insulin levels were lowest 
in the RRPW group among the experimental groups (P <0 . 0 5 )  
(Table 1). 
We then determined the role of RRP treatment on carbohydrate 
metabolism enzyme activities in diabetic model animals, as 
shown in Table 2. The activities of hepatic glucokinase, G6PD, 440 Hypoglycemic action of Rehmannie Radix Preparata
Table 1. Effects of Rehmannie Radix extract on the level of blood glucose and
insulin in streptozotocin-induced diabetic rats
Groups Glucose (mg/dL) Insulin (ng/mL)
Normal control 62.20 ± 6.80
4,5)c 3.94 ± 0.79
a
Diabetic control
1) 332.40 ± 21.30
a 1.45 ± 0.30
b
RRP50
2) 141.02 ± 6.31
b 1.57 ± 0.11
b
RRP100
3) 111.12 ± 4.42
b,c 1.45 ± 0.21
b
RRPW
4) 168.02 ± 12.52
b 0.63 ± 0.15
c
1) Streptozotocin  (50  mg/kg  body  weight)-induced  diabetic  rats 
2) Streptozotocin-induced diabetic rats treated with RRP extract in 50% ethanol by 
daily  oral  administration  (5  mg/kg  body  weight)  for  21  days
3) Streptozotocin-induced  diabetic  rats  treated  with  RRP  extract  in  100%  ethanol 
b y  d a i l y  o r a l  a d m in i s t r a t i o n  ( 5  m g / k g  b o d y  w e i g h t )  f o r  2 1  d a y s 
4) Streptozotocin-induced diabetic rats treated with RRP extract in water by daily 
oral  administration  (5  mg/kg  body  weight)  for  21  days
5) Data  are  expressed  as  mean ± SD  (n = 5). 
6) V alu es w ith  d ifferen t su p erscrip ts w ith in  the co lum n  are sig n ificantly different at 
P < 0.05  by  Duncan's  multiple  range  test.
Table 2. Effects of Rehmannie Radix extract on carbohydrate enzyme activities in streptozotocin-induced diabetic rats
Groups Glucokinase 
(unit/mg protein)
G6PD
5)
(unit/mg protein)
6PGD
6)
(unit/mg protein)
ACC
7)
(nmole/min/mg protein)
Normal control 55.12 ± 4.43
6)a7) 400.02 ± 52.12
a 40.33 ± 5.12
c 0.30 ± 0.07
a
Diabetic control
1) 17.21 ± 2.21
c 51.00 ± 4.32
c 5.12 ± 2.12
d 0.17 ± 0.03
b
RRP50
2) 30.22 ± 1.32
b 110.34 ± 12.11
b 90.24 ± 4.23
a 0.38 ± 0.09
a
RRP100
3) 34.12 ± 2.18
b 190.21 ± 22.32
b 60.11 ± 4.44
b 0.40 ± 0.10
a
RRPW
4) 15.02 ± 3.24
c 50.10 ± 2.56
c 8.09 ± 2.11
d 0.34 ± 0.05
a
1) Streptozotocin  (50  mg/kg  body  weight)-induced  diabetic  rats 
2) Streptozotocin-induced  diabetic  rats  treated  with  RRP  extract  in  5 0 %  e t h a n o l  b y  d a il y  o r a l  a d m i n i s t r a t i o n  ( 5  m g / k g  b o d y  w e ig h t)  for  21  days
3) Streptozotocin-induced  diabetic  rats  treated  with  RRP  extract  in  100%  ethanol  by  daily  oral  administration  (5  mg/kg  body  weight )  f o r  2 1  d a y s 
4) Streptozotocin-induced  diabetic  rats  treated  with  RRP  extract  in  water  by  daily  oral  administration  (5  mg/kg  body  weight)  for  21  days
5) glucose-6-phosphate  dehydrogenase 
6) 6-phosphogluconate-dehydrogenase
7) Acetyl-CoA  carboxylase 
8) Data  are  expressed  as  mean ± SD  (n = 5). 
9) V a l u e s  w i t h  d i f f e r e n t  s u p e r s c r i p t s  w i t h i n  t h e  c o l u m n  a r e  s i g n i ficantly  different  at  P < 0.05  by  Duncan's  multiple  range  test.
G6PDH, and acetyl Co A carboxylase in STZ-induced rats were 
reduced significantly compared to the normal control rats. Both 
the RRP 50 and RRP 100 groups evidenced significantly improved 
glucokinase activity in the liver, as observed in Table 2 (P < 
0.05).
The results of this study demonstrated that the reduction in 
G6PDH activity in diabetic rats (51 unit) is significantly regulated 
by treatment with RRP 50 (110 unit), and RRP 100 (190 unit) 
(P < 0.05) as shown in Table 2.
The other HMP enzyme, 6PGD, is an oxidative carboxylase 
which catalyzes the decarboxylating reduction of 6-phosphogluconate 
into ribulose 5-phosphate in the presence of NADP. The observed 
reduction in the 6PGD activity of diabetic rats (5 unit) was 
reversed significantly by RRP 50 (90 unit) and RRP 100 (60 
unit), respectively, whereas normal rats had 40 units, as shown 
in Table 2 (P <0 . 0 5 ) .  
The significant reduction in the ACC activity of diabetic rats 
(0.17 nmole/min/mg protein) was significantly increased to the 
level of normal rats (0.30 nmole/min/mg protein) by the treatment 
of RRP 50 (0.38 nmole/min/mg protein) and RRP 100 (0.40 
nmole/min/mg protein), respectively (P< 0.05, Table 2). RRPW 
did not stimulate other carbohydrate metabolism enzymes, but 
rather normalized hepatic ACC activity (P< 0.05) in the present 
study (Table 2). 
Discussion
In this study, hypoglycemic action of RRP ethanol extract was 
determined in the streptozotocin (STZ)-injected rats by altering 
activities of glucose metabolic enzymes. Because there is a lack 
of studies on RRP as a single treatment in diabetes, it is not 
easy to compare the present results with others. However, blood 
glucose lowering effect was shown by the crude extract 
administration of dried RR in diabetic nephropathy model [9]. 
Kim  et al. [5] proved anti-diabetic effects of herbal formula 
including RRP. Also, Park et al. [6] reported that administration 
of three radix complexes of RR, Ginseng and Scutellariae 
lowered plasma glucose in diabetic rats. On the other hand, it 
has been reported that 7 days of treatment with RR water extract 
exerted no significant glycemic control effects in neonatal 
STZ-rats, although a trend toward decreasing plasma glucose 
levels was noted and it was effective in promoting diabetic foot 
ulcer healing in rats via inflammation control [4]. 
The selective destruction of pancreatic beta cells was derived 
from STZ injection, resulting in an apparent decline in insulin 
levels [10]. Interestingly, plasma insulin level was not stimulated 
by the oral administration of RRP ethanol extract, and it was 
significantly lowered in the RRPW group among the 
experimental groups (P < 0.05) (Table 1). This result strongly 
indicated that certain lipid soluble substances in RRP should exert 
a hypoglycemic effect independent of insulin secretion. It needs 
to be studied whether RRPW has possible toxicity on the 
pancreas physiology, because RRPW has significantly reduced 
insulin secretion compared to STZ control group in this study. 
Also, since there were quite different results in glucose 
metabolism between RRP 50 and RRPW, the possible effects 
of RRP extracts in other solvent systems need to be determined. 
Glucokinase closes the KATP channel, resulting in efficient 
insulin secretion when serum glucose is elevated. Simultaneously, Shin-Jyung Kang et al. 441
it functions as one of the key enzymes in glucose catabolism, 
phosphorylating glucose and converting it into glucose-6- 
phosphate; glucokinase levels have been shown to be altered in 
diabetes. This results in a decline in glycolysis and reduced 
utilization of glucose for energy production [6,11,12]. This study 
demonstrated that the specific activity of hepatic glucokinase, 
an insulin-inducible enzyme and the major enzyme in the 
phosphorylation of glucose in the liver, was reduced in diabetic 
animals. Additionally, the administration of RRP 50 and RRP100 
significantly returns glucokinase activity to the similar value of 
normal control animals. Similarly, another herbal extract of 
Angelica gigas (AG) radix has hypoglycemic effect in STZ- 
induced rat [13]. 
G6PD, a housekeeping enzyme, catalyzes the first and rate- 
limiting step of the hexose monophosphate shunt (HMP) and 
generates the NADPH required for the maintenance of reduced 
glutathione and reductive biosynthesis [14]. The activity of G6PD 
is also regulated via alternative splicing in response to hormonal 
and nutritional cues such as glucose and lipids. Modest changes 
in G6PD itself exert significant effects on cell growth and cell 
death in a variety of cell types. The observed reduction in G6PD 
activity in diabetic rats also may suggest a reduction in 
metabolism via the phosphogluconate oxidation pathway [15-17].
The present study showed that the reduction in G6PDH activity 
in diabetic rats (51 unit) is significantly regulated to 110 unit 
by the treatment with RRP 50, and to 190 unit by the treatment 
with RRP 100, respectively (P < 0.05). In comparison, Park et 
al. [13] reported that treatment with AG radix extract in STZ- 
injected rats resulted in an enhancement of G6PD activity to 38 
units (AG in 50% ethanol), and 69 units (AG in 100% ethanol). 
The other HMP enzyme, 6PGD, is an oxidative carboxylase 
which catalyzes the decarboxylating reduction of 6-phosphogluconate 
into ribulose 5-phosphate in the presence of NADP [18]. The 
reduced activity of 6PGD in diabetic rats (5 unit/mg) was 
reversed by RRP 50 administration to 18 fold (90 unit/mg) and 
by RRP 100 administration to 12 fold (60 unit/mg), respectively, 
as shown in Table 2 (P < 0.05).
On the contrary to this, the administration of AG radix extract 
did not enhance the 6PGD activity in the previous study [13]. 
Thus, RRP is a better enzymatic regulator of carbohydrate 
catabolism than Angelica gigas radix extract, which has been 
previously employed in complex prescriptions with RRP in 
oriental medicine. 
Acetyl-CoA carboxylase (ACC) catalyzes the biotin-dependent 
carboxylation of acetyl-CoA, thereby generating malonyl-CoA 
[19]. This is the first step, and the commitment point, in the 
biosynthesis of long-chain fatty acids. Simultaneously, a second 
isoform of ACC, ACC2, is associated with the mitochondrial 
membrane and produces malonyl-CoA, which regulates fatty acid 
oxidation by profoundly inhibiting the carnitine palmitoyltransferases 
(CPT-Is). Mice deficient in ACC2 show elevated fatty acid 
oxidation and reduced body fat content and body weight, despite 
the fact that they consume more food. Therefore, inhibitors 
against ACCs might prove efficacious in treating obesity and 
diabetes [19]. ACC-specific activity is also rapidly modulated, 
and increased in response to insulin and reduced after the 
exposure of cells to catabolic hormones or environmental stress 
conditions [20]. In our study, RRP ethanol extract showed the 
significant reversal potential in the ACC activity of diabetic rats 
to the level of normal rats (P < 0.05, Table 2). This result is 
also comparable to the observed enhancement effect on ACC 
activity of AG extract (0.29-0.31 nmole/min/mg protein) in 
STZ-injected rats. Thus, the results of this study demonstrated 
that simultaneous activations of RRP extracts--particularly 100% 
ethanol extract--on hepatic glucokinase, G6PD, 6PGD, and ACC 
contributed to hypoglycemic regulation in STZ-injected rats. It 
should be considered important to select the appropriate solution 
to enhance the hypoglycemic control characteristics of the RRP 
extract.
In conclusion, the administration of RRP ethanol extract to 
streptozotocin-induced diabetic rats restored the key enzyme 
activities in glucose metabolism and reversed blood glucose 
concentration. The findings of this study demonstrate that RRP 
ethanol extract has complementary potency for widespread use 
in treating diabetes in the future.
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